These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 7797131)
1. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131 [TBL] [Abstract][Full Text] [Related]
2. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444 [TBL] [Abstract][Full Text] [Related]
3. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Van Laethem JL; Bourgeois V; Parma J; Delhaye M; Cochaux P; Velu T; Devière J; Cremer M Gastrointest Endosc; 1998 Jun; 47(6):479-85. PubMed ID: 9647372 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions. Trümper LH; Bürger B; von Bonin F; Hintze A; von Blohn G; Pfreundschuh M; Daus H Br J Cancer; 1994 Aug; 70(2):278-84. PubMed ID: 8054276 [TBL] [Abstract][Full Text] [Related]
5. Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer. Zhou GX; Huang JF; Li ZS; Xu GM; Liu F; Zhang H World J Gastroenterol; 2004 May; 10(9):1337-40. PubMed ID: 15112354 [TBL] [Abstract][Full Text] [Related]
6. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas]. Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522 [TBL] [Abstract][Full Text] [Related]
7. [Gene diagnosis of pancreatic adenocarcinoma]. Wang ZY; Liu TH; Cui QC Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):270-3. PubMed ID: 7874757 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases. Pugliese V; Pujic N; Saccomanno S; Gatteschi B; Pera C; Aste H; Ferrara GB; Nicolò G Gastrointest Endosc; 2001 Nov; 54(5):595-9. PubMed ID: 11677475 [TBL] [Abstract][Full Text] [Related]
9. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484 [TBL] [Abstract][Full Text] [Related]
10. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice. Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537 [TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer. Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992 [TBL] [Abstract][Full Text] [Related]
12. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma. Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168 [TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer. Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770 [TBL] [Abstract][Full Text] [Related]
14. Ki-ras oncogene mutations in chronic pancreatitis: which discriminating ability for malignant potential? van Laethem JL Ann N Y Acad Sci; 1999 Jun; 880():210-8. PubMed ID: 10415866 [TBL] [Abstract][Full Text] [Related]
15. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Tada M; Omata M; Ohto M Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826 [TBL] [Abstract][Full Text] [Related]
16. Analysis of K-ras codon 12 point mutations using duodenal lavage fluid for diagnosis of pancreatic carcinoma. Nakamura Y; Onda M; Uchida E Pancreas; 1999 Mar; 18(2):133-40. PubMed ID: 10090410 [TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983 [TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. Maire F; Micard S; Hammel P; Voitot H; Lévy P; Cugnenc PH; Ruszniewski P; Puig PL Br J Cancer; 2002 Aug; 87(5):551-4. PubMed ID: 12189555 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice. Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672 [TBL] [Abstract][Full Text] [Related]
20. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Motojima K; Urano T; Nagata Y; Shiku H; Tsurifune T; Kanematsu T Ann Surg; 1993 Feb; 217(2):138-43. PubMed ID: 8439212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]